Archive for January, 2007

Gene Segment Identified in Virulent Human H5N1 Viruses – Key Discovery May Enable Development of Vaccines, Therapeutics

By PR Web - Last updated: Thursday, January 25, 2007

Viruses whose genomes constantly mutate, such as the H5N1 “bird flu”, are driving a race to find relatively unchanging segments of their genomes; successful identification of these segments may allow more successful vaccines and therapeutics to be developed. (PRWeb Jan 25, 2007)

Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/UGlnZy1UaGlyLVNpbmctWmV0YS1NYWduLVplcm8=

Nobel Laureate James Watson Supports Applications of Recombinant DNA Technology in Agriculture

By PR Web - Last updated: Tuesday, January 23, 2007

Dr. James Watson expounds on his support for applications of recombinant DNA technology in agriculture in a brief and exclusive video made available today at the Conversations about Plant Biotechnology Web site. (PRWeb Jan 22, 2007)

Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/SGFsZi1QaWdnLUNyYXMtTG92ZS1NYWduLVplcm8=

2nd Annual Albert Szent-Györgyi Prize for Progress in Cancer Research Awarded to Webster K. Cavenee, Ph.D.

By PR Web - Last updated: Friday, January 19, 2007

The National Foundation for Cancer Research (NFCR) announced today that Webster K. Cavenee, Ph.D. has been awarded the 2nd Annual Albert Szent-Györgyi Prize for Progress in Cancer Research. Dr. Cavenee, Director of the Ludwig Institute for Cancer Research and Distinguished Professor at the University of California, San Diego, won the prize for his groundbreaking discoveries regarding the genetic mechanisms of predisposition to human cancer. (PRWeb Jan 19, 2007)

Illinois Researchers Break Billion Variable Optimization Barrier

By PR Web - Last updated: Friday, January 19, 2007

Researchers at the University of Illinois have demonstrated effective scalability of genetic algorithms on optimization problems larger than a billion variables. (PRWeb Jan 19, 2007)

Post Comment:Trackback URL: http://www.prweb.com/dingpr.php/SW5zZS1UaGlyLVpldGEtTG92ZS1NYWduLVplcm8=

GenJetâ„¢ DNA In Vitro Transfection Reagent: A Hybrid of Cationic Liposome and Polymer at $139/ml

By PR Web - Last updated: Thursday, January 18, 2007

A novel DNA in vitro transfection reagent —– GenJet? is introduced by SignaGen Laboratories (SignaGen) at $139 per ml, only 55% of cost compared with major brand name products. GenJet? DNA In Vitro Transfectio Reagent, a hybrid of cationic liposome and polymer, exhibits superior transfection efficiency with extremely low toxicity at affordable price, especially benefiting those high-volume users and low-budget laboratories. (PRWeb Jan 18, 2007)

New Website Brings Insights and Information on Lifestyle and Genes Directly to Consumers

By PR Web - Last updated: Tuesday, January 16, 2007

Sciona, Inc. Announces Launch of MyCellf.com ushering in a new era of consumer focused DNA and lifestyle conversations (PRWeb Jan 16, 2007)

Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/TWFnbi1Db3VwLVRoaXItTG92ZS1NYWduLVplcm8=